Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abcellera Biologics Inc (NQ: ABCL )

2.720 +0.050 (+1.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abcellera Biologics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Wednesday Is A Normal Day
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
Wednesday morning, 7 companies reached new 52-week lows. Interesting Points: AbCellera Biologics (NASDAQ:ABCL) was the largest firm by market cap to set a new 52-... 
Via Benzinga
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss. SeaChange International... 
Via Benzinga
AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada
From AbCellera Biologics Inc.
Via Business Wire
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's morning session, 22 companies made new 52-week lows. Key Facts: China Life Insurance Co (NYSE:LFC) was the largest, in terms of market cap, to... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET on Thursday, 16 companies hit new 52-week lows. Areas of Interest: Vertex Pharmaceuticals (NASDAQ:VRTX) was the biggest company by market cap to... 
Via Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
Dreary Day
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. 
Via Talk Markets
Happy Friday
The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer. 
Via Talk Markets
AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares
From AbCellera Biologics Inc.
Via Business Wire
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
New New Deal Worries
Nio is up 1.4% today on another round of Meme buying. 
Via Talk Markets
The Surprising Move Vir Stock Made After Winning Covid Drug Authorization
GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday. 
Via Investor's Business Daily
Exposures COVID-19
Sterling At Five-Year High
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
60 Biggest Movers From Yesterday
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... 
Via Benzinga
Worldwide Upbeat
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Another Tough Day For Markets
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” 
Via Talk Markets
CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results
From AbCellera Biologics Inc.
Via Business Wire
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter. 
Via Investor's Business Daily
AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript
ABCL earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
AbCellera Reports Q1 2021 Business Results
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Present Virtually at Berenberg Conference on May 18, 2021
From AbCellera Biologics Inc.
Via Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
From AbCellera Biologics Inc.
Via Business Wire
Finns and Danes
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
Merry Month of May
Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.